Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000343763

Medchemexpress LLC UK122 TFA | 940290-58-4 | 99.85% | 405.33 | 1 ML
SDP

Catalog No. 5000343763
Encompass_Preferred

UK122 is a potent and selective urokinase-type plasminogen activator (uPA) inhibitor with an IC50 of 0.2 μM. It exhibits little to no inhibition of tissue-type PA (tPA), plasmin, thrombin, and trypsin (all IC50>100 μM). This 4-oxazolidinone analogue acts as an anticancer agent by inhibiting cancer cell migration and invasion.

  • Potent and selective urokinase-type plasminogen activator (uPA) inhibitor.
  • IC50 of 0.2 μM for uPA.
  • Minimal inhibition of tPA, plasmin, thrombin, and trypsin (IC50 > 100 μM).
  • 4-oxazolidinone analogue.
  • Acts as an anticancer agent.
  • Inhibits cancer cell migration and invasion.
  • For research use only.

Catalog No. 50-003-43763 Supplier Medchemexpress LLC Supplier No. HY11105610MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

UK122 is a potent and selective urokinase-type plasminogen activator (uPA) inhibitor with an IC50 of 0.2 μM. It exhibits little to no inhibition of tissue-type PA (tPA), plasmin, thrombin, and trypsin (all IC50>100 μM). This 4-oxazolidinone analogue acts as an anticancer agent by inhibiting cancer cell migration and invasion.

  • Potent and selective urokinase-type plasminogen activator (uPA) inhibitor.
  • IC50 of 0.2 μM for uPA.
  • Minimal inhibition of tPA, plasmin, thrombin, and trypsin (IC50 > 100 μM).
  • 4-oxazolidinone analogue.
  • Acts as an anticancer agent.
  • Inhibits cancer cell migration and invasion.
  • For research use only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.